Home  |  Contact
Due to scheduled maintenance work, this service will not be available from Tuesday August 23rd 06:00 pm until Wednesday August 24th 08:00 am CEST. Apologies for the inconvenience.

Cellosaurus MB49 (CVCL_7076)

[Text version]

Cell line name MB49
Synonyms MB-49
Accession CVCL_7076
Resource Identification Initiative To cite this cell line use: MB49 (RRID:CVCL_7076)
Comments Karyotypic information: Has lost chromosome Y (PubMed=22559978).
Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
Derived from sampling site: Urinary bladder.
Disease Mouse bladder transitional cell carcinoma (NCIt: C25823)
Species of origin Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Breed/subspecies: C57BL/ICRF-a(t).
Hierarchy Children:
CVCL_VL62 (MB49-I )
Sex of cell Male
Age at sampling Adult
Category Cancer cell line
STR profile Source(s): Millipore

Markers:
Mouse STR 1-115,16
Mouse STR 1-219
Mouse STR 2-116
Mouse STR 3-213,14
Mouse STR 4-220.3
Mouse STR 5-517
Mouse STR 6-418
Mouse STR 6-715
Mouse STR 7-126.2
Mouse STR 8-116
Mouse STR 11-216
Mouse STR 12-117
Mouse STR 13-117
Mouse STR 15-322.3
Mouse STR 17-214,15
Mouse STR 18-316
Mouse STR 19-214
Mouse STR X-128,29

Run an STR similarity search on this cell line
Publications

PubMed=107359; DOI=10.1093/jnci/62.4.1017
Summerhayes I.C., Franks L.M.
Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro.
J. Natl. Cancer Inst. 62:1017-1023(1979)

PubMed=19539312; DOI=10.1016/j.juro.2009.03.076
Lodillinsky C., Rodriguez V., Vauthay L., Sandes E., Casabe A., Eijan A.M.
Novel invasive orthotopic bladder cancer model with high cathepsin B activity resembling human bladder cancer.
J. Urol. 182:749-755(2009)

PubMed=22559978; DOI=10.1016/j.cancergen.2012.02.002
Fabris V.T., Lodillinsky C., Pampena M.B., Belgorosky D., Lanari C., Eijan A.M.
Cytogenetic characterization of the murine bladder cancer model MB49 and the derived invasive line MB49-I.
Cancer Genet. 205:168-176(2012)

PubMed=29732388; DOI=10.3233/BLC-180167
Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.
Systematic review: characteristics and preclinical uses of bladder cancer cell lines.
Bladder Cancer 4:169-183(2018)

PubMed=29784854; DOI=10.1158/0008-5472.CAN-18-0173
Saito R., Smith C.C., Utsumi T., Bixby L.M., Kardos J., Wobker S.E., Stewart K.G., Chai S.-J., Manocha U., Byrd K.M., Damrauer J.S., Williams S.E., Vincent B.G., Kim W.Y.
Molecular subtype-specific immunocompetent models of high-grade urothelial carcinoma reveal differential neoantigen expression and response to immunotherapy.
Cancer Res. 78:3954-3968(2018)

PubMed=30867744; DOI=10.3892/ol.2019.9995
Alberto M., Cuello H.A., Gulino C.A., Pifano M., Belgorosky D., Gabri M.R., Eijan A.M., Segatori V.I.
Expression of bladder cancer-associated glycans in murine tumor cell lines.
Oncol. Lett. 17:3141-3150(2019)

Cross-references
Cell line collections AddexBio; C0002004/5005
CancerTools; 153368
Millipore; SCC148
Ximbio; 153368
Anatomy/cell type resources BTO; BTO:0003562
Encyclopedic resources Wikidata; Q54904112
Entry history
Entry creation04-Apr-2012
Last entry update23-Jun-2022
Version number13